Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-25T14:47:07.189Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical Pathways for Mood and Anxiety Disorders

Published online by Cambridge University Press:  07 November 2014

Waguih William IsHak
Get access Rights & Permissions [Opens in a new window]

Abstract

Clinical pathways generally recommend potential steps in the diagnosis and treatment of a condition or procedure for individual patients. Their usefulness in guiding clinicians through the steps of nonresponse or partial response to interventions has been documented. They are predominantly management tools based on clinical information developed from evidence-based psychiatry, practice guidelines, or expert consensus statements. Pathways may not be appropriate for use in all circumstances, nor are they a substitute for the practitioner's experience and judgment. Their applicability must be assessed by the responsible practitioner in light of relevant circumstances presented by individual patients in order to optimize treatment.

Type
Research Article
Information
CNS Spectrums , Volume 9 , Issue S14: Treatment Resistance: Concepts and Management in Mood and Anxiety Disorders , December 2002 , pp. 18 - 24
Copyright
Copyright © Cambridge University Press 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Wigfield, A, Boon, E. Critical care pathway development: the way forward. Br J Nursing. 1996;5(12):732–735.Google Scholar
2.Bernstein, CA, IsHak, WW. Outcome measurement: training psychiatry residents In: Outcome Measurement In Psychiatry: A Critical Review. IsHak, WW, Burt, T, Sederer, LI, eds. Washington, DC: American Psychiatric Publishing, Inc; 2002:377–382.Google Scholar
3.Hill, M. CareMap and case management systems; evolving models designed to enhance direct patient care. In: Reengineering Nursing and Healthcare, The Handbook for Organisational Transformation. Blancett, SS, Flarey, DL, eds. Gaithersburg, MD: Aspen Publishers; 1995:177.Google Scholar
4.IsHak, WW, Merlino, J, Trujillo, M. Example of a depression treatment and outcome monitoring pathway. In: IsHak, WW, Burt, T, Sederer, LI, eds. Outcome Measurement in Psychiatry: A Critical Review. Washington, DC: American Psychiatric Publishing, Inc; 2002:405–418.Google Scholar
5.Rush, AJ, Crismon, ML, Toprac, MG, et al.Consensus guidelines in the treatment of major depressive disorder. J Clin Psychiatry. 1998;59(Suppl 20):73–84.Google ScholarPubMed
6.Sachs, GS, Printz, DJ, Kahn, DA, Carpenter, D, Docherty, JP. The Expert Consensus Guidelines Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med Spec. 2000;Special Report(04):1–104.Google Scholar
7.AJ, Frances, Kahn, DA, Carpenter, D, Docherty, JP, Donovan, SL. The Expert Consensus Guidelines for treating depression in bipolar disorder. J Clin Psychiatry. 1998;59(Suppl 4):73–79.Google Scholar
8.American Psychiatric Asscdation Practice Guidelines for the Treatment of Psychiatric Disorders, Compendium 2004. Washington, DC: American Psychiatric Press; 2004.Google Scholar
9.Depression Guideline Panel. Depression in Primary Care. Vol. 2. Treatment of Major Depression. Clinical Practice Guideline. Rockville, MD: US Dept. of Health and Human Services, Agency for Health Care Policy and Research, AHCPR Publication No. 93-0551; 1993.Google Scholar
10.Crismon, ML, Trivedi, M, Pigott, TA, et al.The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. J Clin Psychiatry. 1999;60(3):142–156.Google Scholar
11.Trivedi, MH, Shon, S, Crismon, ML, Key, T. Texas Implementation of Medication Algorithms (TIMA) Guidelines For Treating Major Depressive Disorder, TIMA Physician Procedural Manual. Available at: http://www.mhmr.state.tx.us/central-office/medicaldirector/timaMDDman.pdf. 2000. Accessed: October 2004.Google Scholar
12.IsHak, WW, Burt, T. Outcome measurement in mood disorders. In: IsHak, WW, Burt, T, Sederer, LI, eds. Outcome Measurement in Psychiatry: a Critical Review. Washington, DC: American Psychiatric Publishing, Inc; 2002:155–190.Google Scholar
13.AJ, Rush, Giles, DE, Schlesser, MA, et al.The Inventory for Depressive Symptomatology (IDS): Preliminary findings. Psychiatry Res. 1986;18(1)65–87.Google Scholar
14.Sheehan, DV, Lecrubier, Y, Harnett, SK, et al.Reliability and validity of the MINI International Neuropsychiatric Interview (MINI): according to the SCID-P. Eur Psychiatry. 1997;12:232–241.Google Scholar
15.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
16.Persons, JB, Thase, ME, Crits-Christoph, P. The role of psychotherapy in the treatment of depression: review of two practice guidelines. Arch Gen Psychiatry. 1996;53(4):283–290.Google Scholar
17.Nemeroff, CB, Heim, CM, Thase, ME, et al.Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci U S A. 2003;100(24):14293–14296.Google Scholar
18.Compton, MT, Nemeroff, CB. The treatment of bipolar depression. J Clin Psychiatry. 2000;61(Suppl 9):57–67.Google Scholar
19.Thase, ME, Sachs, GS. Bipolar depression: pharmacotherapy and related therapeutic strategies. Biol Psychiatry. 2000;15;48(6):558–572.Google Scholar
20.National Institute of Mental Health. Anxiety Disorders (NIH Publication Number: 02-3879). Bethesda, MD: National Institute of Mental Health, National Institutes of Health, US Department of Health and Human Services; 2002. Available at: http://www.nimh.nih.gov/publicat/NIMHanxiety.pdf. Accessed: October 2004.Google Scholar
21.Foa, EB, JRT, Davidson, Frances, A. The Expert Consensus Guideline Series: treatment of posttraumatic stress disorder. J Clin Psychiatry. 1999;60(Suppl 16):1–76.Google Scholar
22.March, J, Frances, A, Carpenter, D, Kahn, D. The Expert Consensus Guideline Series: Treatment of Obsessive-Compulsive Disorder. J Clin Psychiatry. 1997;58(Suppl 4):1–72.Google Scholar
23Ballenger, JC, Davidson, JR, Lecrubier, Y, et al.Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 1998;59(Suppl 17):54–60.Google Scholar
24.Peselow, E. Outcome measurement in anxiety disorders. In: IsHak, WW, Burt, T, Sederer, LI, eds. Outcome Measurement in Psychiatry: A Critical Review. Washington, DC: American Psychiatric Publishing, Inc; 2002:191–206.Google Scholar
25.Beck, AT, Steer, RA. Beck Anxiety Inventory. San Antonio, TX: The Psychological Corporation; 1993.Google Scholar
26.Barlow, DH, CL, Lehman. Advances in the psychosocial treatment of anxiety disorders. Implications for national health care. Arch Gen Psychiatry. 1996;53:727–735.Google Scholar
27.US Department of Health and Human Services. Mental Health: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health; 1999.Google Scholar
28.Trivedi, MH, AJ, Rush, Crismon, ML, et al.Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry. 2004;61(7):669–680.Google Scholar
29Keller, MB, McCullough, JP, Klein, DN, et al.A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342(20):1462–1470. Erratum: N Engl J Med. 2001;345(3):232.Google Scholar
30.Leichsenring, F. Comparative effects of short-term dynamic psychodynamic psychotherapy and cognitive-behavior therapy in depression: a meta-analytic approach. Clin Psychol Rev. 2001;21:401–419.Google Scholar
31.Birmaher, B, Brent, DA, Kolko, D, et al.Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Arch Gen Psychiatry. 2000;57(1):29–36.Google Scholar